CristinaMariaMerkhoferMDMHS

Oncology • New York, NY

Head & Neck Cancer, Thoracic Cancer

Medical Oncologist

Join to view full profile

Dr. Merkhofer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Merkhofer's full profile

Already have an account?

Office
233 Spring St
New York, NY 10013
Is this information wrong?

Education & Training

University of WashingtonFellowship, Hematology and Medical Oncology, 2017 - 2020
UPMC Medical EducationResidency, Internal Medicine, 2014 - 2017
University of Wisconsin School of Medicine & Public HealthClass of 2014, MD
Johns Hopkins Bloomberg School of Public HealthMHS, International Health, Global Disease Epidemiology and Control, 2008 - 2010

Certifications & Licensure

WV State Medical License 2024 - 2025
WA State Medical License 2017 - 2024
DC State Medical License 2023 - 2024
PA State Medical License 2014 - 2017
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

17 citations
HER2 in Non-Small Cell Lung Cancer: A Review of Emerging Therapies.
Natalie F Uy, Cristina M Merkhofer, Christina S Baik> ;Cancers. 2022 Aug 27
2 citations
Systemic Treatment Patterns and Outcomes in Patients With EGFR Mutated Non-small Cell Lung Cancer and Leptomeningeal Disease.
Cristina M Merkhofer, Boryana Eastman, Isabella Densmore, Lia M Halasz, Tresa McGranahan, Christina Baik> ;Clinical Lung Cancer. 2022 Jul 1
1 citations
Effect of Clinical Trial Participation on Costs to Payers in Metastatic Non–Small-Cell Lung Cancer
Cristina Merkhofer, Shasank Chennupati, Qin Sun, Keith D. Eaton, Renato G. Martins, Scott D. Ramsey, Bernardo H. L. Goulart> ;JCO Oncology Practice. 2021 Aug 10
1 citations
Durable Response of Leptomeningeal Disease With Osimertinib and Pemetrexed in EGFR-Mutated Metastatic NSCLC: A Case Report.
Cristina Merkhofer, Christina S. Baik> ;JTO Clinical and Research Reports. 2021 Jun 1
3 citations
Impact of Clinical Trial Participation on Survival of Patients with Metastatic Non-Small Cell Lung Cancer.
Cristina Merkhofer, Keith D. Eaton, Renato G. Martins, Scott D. Ramsey, Bernardo H. L. Goulart> ;Clinical Lung Cancer. 2021 Apr 22
Join now to see all

Press Mentions

Clinical Trial Participation Studies Show Possible Survival Benefit, Misconceptions of Patient ConcernsSeptember 5th, 2019
Highlights from ASCO's Quality Care Symposium: A Clinical Trial May Offer the Best Survival Odds for People Battling Non-Small-Cell Lung Cancer, but Not Enough Patients Enroll in ThemSeptember 5th, 2019

Hospital Affiliations

UW Medicine/University of Washington Medical CenterSeattle, Washington